EVALUATION AND COMPARISON OF SAFETY AND EFFICACY OF TWO ANTI-ACNE TEST PRODUCTS ON MILD TO MODERATE ACNE.

OPLO0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•1.Voluntary men/women with 4 acne lesions with nearly the same severity score and similar maturation age (per history) on the entire face.
•2.Age between 18 â?? 25 years.
•3.No treatment for acne in the past 1 month
•4.Phototype III and IV.
•5.All skin types (greasy, normal) except known significant sensitive skin.
•6.Accepting not to use products with the same end benefit during the entire study duration.
•7.For whom the Investigator considers that the compliance will be correct.
•8.Cooperating, informed of the need and duration of the examinations, and ready to comply with protocol procedures.
•9.Having signed a Consent Form and will be once informed orally and in writing of all information concerning the study procedures and study objectives.

•1.Pregnant women and lactating women. In any case of suspicion a pregnancy test shall be preformed.
•2.History suggestive of any hormonal problems.
•3.History of allergic dermatitis or contact allergy to cosmetics,
•4.Subjects on oral retinoid since the past 3 months.
•5.Hypersensitivity to any cosmetic product, raw material.
•6.Any clinically significant systemic or cutaneous disease, which may interfere with study treatments or procedures.
•7.Subjects on any medical treatment either systemic or topical which may interfere with the performance of the study treatment (presently or in the past 1 month).
•8.Subject in an exclusion period or participating in another similar cosmetic or therapeutic trial.

发起方

OPLO